Related Experiment Video
Updated: Apr 12, 2026

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
Published on: June 8, 2022
Structural insights into subtype-specific agonist recognition by sphingosine-1-phosphate receptors
Leiye Yu1,2, Haizhan Jiao3, Bin Pang1
1Shanghai Key Laboratory of Metabolic Remodeling and Health, Institute of Metabolism and Integrative Biology, Shanghai Xuhui Central Hospital, Zhongshan-Xuhui Hospital, Fudan University, Shanghai, China.
Structural insights reveal how specific agonists selectively bind to Sphingosine-1-phosphate receptor 1 (S1PR1) over other subtypes. This understanding aids in designing targeted therapies for S1PR1-related conditions.
Area of Science:
- Structural biology
- Pharmacology
- Biochemistry
Background:
- Sphingosine-1-phosphate (S1P) is a critical sphingolipid metabolite regulating physiological and pathological processes.
- S1P exerts its functions by activating five G protein-coupled sphingosine-1-phosphate receptors (S1PR1-5).
Purpose of the Study:
- To elucidate the molecular determinants governing agonist selectivity for S1PR1 over other S1PR subtypes.
- To provide a structural basis for designing highly selective S1PR1 agonists for therapeutic development.
Main Methods:
- Cryo-electron microscopy (cryo-EM) to determine structures of agonist-bound S1PR1-Gi1 complexes.
- Molecular dynamics (MD) simulations to analyze binding interactions and dynamics.
- Pharmacological assays to validate selectivity profiles.
Main Results:
- Identified nonconserved residues and distinct agonist binding orientations contributing to S1PR1 selectivity.
- Demonstrated how steric clashes and restricted insertion into binding pockets of S1PR3 and S1PR5 enhance S1PR1 selectivity.
- Revealed that bulky side chains in S1PR2 and S1PR4 pockets hinder binding of broad-width agonists.
Conclusions:
- Established a structural framework for understanding S1PR1 agonist selectivity.
- Findings facilitate the rational design of next-generation, highly selective S1PR1 agonists with enhanced therapeutic potential.
Related Concept Videos
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Opioid Receptors: Overview
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...

